NetraMark HoldingsAINMF +14.62%22 Return-on-Tangible-Equity is -402.53% as of Mar. 2026. GuruFocus rates AINMF with a GF Score™ of 22/100 and a GF Value™ of $0.18 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 582 Healthcare Providers & Services companies, NetraMark Holdings ranks worse than 97.42% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. NetraMark Holdings's annualized net income for the quarter that ended in Mar. 2026 was $-6.37 Mil. NetraMark Holdings's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $1.58 Mil. Therefore, NetraMark Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -402.53%.
The historical rank and industry rank for NetraMark Holdings's Return-on-Tangible-Equity or its related term are showing as below:
AINMF'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -10304.73 Med: -561.35 Max: -15.98
Current: -359.37
During the past 6 years, NetraMark Holdings's highest Return-on-Tangible-Equity was -15.98%. The lowest was -10,304.73%. And the median was -561.35%.
AINMF's Return-on-Tangible-Equity is ranked worse than 97.42% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs AINMF: -359.37
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
NetraMark Holdings Return-on-Tangible-Equity Related Terms
NetraMark Holdings Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for NetraMark Holdings's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AINMF vs VEEV, BTSG, TEM: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, NetraMark Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NetraMark Holdings Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where NetraMark Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -402.53% mean?
NetraMark Holdings (AINMF) has a Return-on-Tangible-Equity of -402.53% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on NetraMark Holdings and its competitors. According to the industry distribution chart, NetraMark Holdings ranks #567 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 97.4%.
Is NetraMark Holdings' Return-on-Tangible-Equity too high?
NetraMark Holdings' current Return-on-Tangible-Equity is -402.53%. Based on the distribution chart, NetraMark Holdings ranks #567 out of 582 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NetraMark Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NetraMark Holdings' Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NetraMark Holdings ranks #567 out of 582 companies for Return-on-Tangible-Equity. This places NetraMark Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.07. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on NetraMark Holdings and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NetraMark Holdings's current Return-on-Tangible-Equity is -402.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NetraMark Holdings stock overvalued right now?
Based on GuruFocus' analysis, NetraMark Holdings (AINMF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.18, compared to a current price of $0.46 — trading 155.6% above its estimated fair value. The current Return-on-Tangible-Equity is -402.53%. NetraMark Holdings' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For NetraMark Holdings (AINMF), the current Return-on-Tangible-Equity is -402.53% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NetraMark Holdings (AINMF) Overvalued in 2026?
Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued.
The current stock price of $0.46 is trading 155.6% above its estimated GF Value™ of $0.18.
GuruFocus considers NetraMark Holdings to be Significantly Overvalued.
Key valuation signals for AINMF:
Return-on-Tangible-Equity: -402.53%
GF Value™: $0.18 vs. price of $0.46 (155.6% above fair value)
No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
22GF Score
Get the complete analysis for AINMF
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINMF has been successfully added to your 
